Brief: Genovis Receives $4 Mln After Selecta Biosciences Sublicenses Xork Enzyme To Astellas Pharma
09/01/2023 13:06
Jan 9 (Reuters) - Genovis AB GENOb.ST :
* GENOVIS TO RECEIVE 4 MUSD UPFRONT AFTER SELECTA
BIOSCIENCES
SUBLICENSED XORK™ ENZYME TO ASTELLAS PHARMA
Source text for Eikon: ID:nWkr91R1P6
Further company coverage: GENOb.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))